Genes & biomarkers

Understanding gene and biomarker results

Somatic / germline · pathogenic / VUS · tissue / blood

Read the alteration, sample and clinical meaning together, beyond the gene name.

Sources checked · Introductory guide

On this page

Start with the report details

Record the gene, exact variant or fusion partner, alteration type, test date and sample. A listed drug still requires review of cancer type, stage, treatment history and access criteria; benefit is not guaranteed.[1]

Does a tumor variant mean inherited risk?

Somatic changes arise in some cells; germline variants are present from birth and may concern relatives. Tumor testing does not replace inherited-risk testing. A suspected germline finding may need counseling and confirmation with an appropriate separate sample.[2]

A VUS is not a pathogenic result

A variant of uncertain significance (VUS) lacks enough evidence for a clear harmful classification. In inherited-risk testing, a VUS alone should not determine preventive surgery or relatives’ risk. Keep the report and ask about reclassification updates.[2]

Does no finding mean no target?

Test coverage and sample quantity/quality affect results. Distinguish “not detected” from “insufficient sample” or a failed test. Depending on the situation, a blood result may need tissue follow-up. Discuss whether and when to repeat testing.[3]

Questions for your care team

  • Is my finding pathogenic or a VUS, and how strong is the treatment evidence?
  • Do I need tissue follow-up, repeat testing or genetic counseling?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Biomarker Testing for Cancer Treatment (opens in a new tab)
  2. NCI · Genetic Testing for Inherited Cancer Risk (opens in a new tab)
  3. ESMO · Recommendations on circulating tumour DNA assays (2022) (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Understanding gene and biomarker results | Cancer Encyclopedia | My Chemo Diary